Disclosure Under Regulation 7(2)(B) of the SEBI (Prohibition of Insider Trading) Regulations, 2015

Promoter Stake BuyOwnership Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+10.1%1-day move

₹69.49

prior close

₹71.10

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-1.5-1.5+0.2-1.5+10.1+12.8+11.5+13.3+11.5+12.2+3.6+3.6+31.5+60.2

Up moveDown movePending

AI summary

Hannah Joseph Hospital has disclosed that its Promoter and Managing Director, Dr. Mosesjoseph Arunkumar, purchased 46,000 equity shares of the company on 30 March 2026 through on-market trades on BSE. The acquisition took his holding from 15,708,925 shares (69.41%) to 15,754,925 shares (approximately 69.61%). The disclosure was filed in Form C under Regulation 7(2)(b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The exact rupee value of the transaction is not clearly readable in the filing, though the share count is confirmed by the pre- and post-trade totals.

Likely market impact

This is a modest promoter buy (about 0.20% increase in promoter holding) and signals continued insider confidence in the company. The holding remains comfortably above 69%, so there is no meaningful shift in control or promoter commitment level for retail shareholders.